You are here
Home ›
Presentations › Application of an antibody-independent, highly sensitive PRISM-SRM proteomics approach for monitoring TMPRSS2-ERG fusion proteins in prostate cancer cell lines and tumor tissues
Application of an antibody-independent, highly sensitive PRISM-SRM proteomics approach for monitoring TMPRSS2-ERG fusion proteins in prostate cancer cell lines and tumor tissues